Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists track how aging changes arthritis symptoms and thinking skills

NCT ID NCT05463666

Knowledge-focused Sponsor: Maastricht University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how getting older affects disease activity, memory, and physical function in people with rheumatoid arthritis (RA) compared to those without RA. Researchers will follow 840 adults aged 55-85, half with RA and half without, using questionnaires and physical tests. The goal is to create age-specific reference charts to help doctors better interpret test results in older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 840 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2022

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

RA patients for the STAR project will be recruited from the outpatient clinics of the MUMC and the Zuyderland Medical Center in Heerlen / Sittard by the rheumatologist. The control population will be recruited through friends and/or family members of patients and controls, snowball sampling; a qualified participant can share an invitation with other subjects similar to them, and recruitment via patient partners of the MUMC. Moreover, patients and controls will be recruited by giving a presentation about the study during a gathering of patients and their family at the Reumacafé, dissemination of flyers during regular information evening of the department of rheumatology at the MUMC and Zuyderland, and recruit via local social (sports) clubs.

Ages

55 to 85 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (RA population): * Age between 55-85 years at baseline. * Diagnosis of RA by treating rheumatologist. Inclusion Criteria (control population): * Age between 55-85 years at baseline. * No diagnosis of RA, or other inflammatory RMD (osteoarthritis allowed). Exclusion Criteria: * Subject is the spouse/partner of the included RA patient. * Have severe comorbidity and the treating rheumatologist and/or research team decides they should not be included in the study because of health reasons. * A diagnosis of dementia or mental incompetency is always reason for exclusion. * Persons of whom the research team estimates that his/her life expectancy is less than 2 years. * Do not understand the Dutch language and/or are notable to understand the study information.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity rheumatic disorder rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rheumatoid arthritis

Contacts and locations

Locations

  • Maastricht UMC+

    Maastricht, Limburg, 6229HX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.